The US administration on Sept 30 announced that Pfizer will cut the price of all prescription drugs in the Medicaid programme for low-income Americans and sell new prescription drugs at a "most favoured nation" price in exchange for tariff relief.
They said the drugs manufactured by Pfizer would be sold at discounts ranging from 40% to 80% on a direct-to-consumer website called TrumpRx.
Be the first to comment